Basic statistics for clinicians: 1. Hypothesis testing
G Guyatt, R Jaeschke, N Heddle, D Cook, H Shannon, S Walter, G Guyatt, R Jaeschke, N Heddle, D Cook, H Shannon, S Walter
Abstract
In the first of a series of four articles the authors explain the statistical concepts of hypothesis testing and p values. In many clinical trials investigators test a null hypothesis that there is no difference between a new treatment and a placebo or between two treatments. The result of a single experiment will almost always show some difference between the experimental and the control groups. Is the difference due to chance, or is it large enough to reject the null hypothesis and conclude that there is a true difference in treatment effects? Statistical tests yield a p value: the probability that the experiment would show a difference as great or greater than that observed if the null hypothesis were true. By convention, p values of less than 0.05 are considered statistically significant, and investigators conclude that there is a real difference. However, the smaller the sample size, the greater the chance of erroneously concluding that the experimental treatment does not differ from the control--in statistical terms, the power of the test may be inadequate. Tests of several outcomes from one set of data may lead to an erroneous conclusion that an outcome is significant if the joint probability of the outcomes is not taken into account. Hypothesis testing has limitations, which will be discussed in the next article in the series.
References
- Biometrics. 1987 Sep;43(3):487-98
- Br Med J (Clin Res Ed). 1988 Apr 30;296(6631):1210-1
- J Clin Epidemiol. 1991;44(8):839-49
- N Engl J Med. 1991 Aug 1;325(5):303-10
- Mayo Clin Proc. 1988 Aug;63(8):813-5
- JAMA. 1992 Nov 4;268(17):2420-5
- JAMA. 1993 Nov 3;270(17):2093-5
- JAMA. 1993 Nov 3;270(17):2096-7
- N Engl J Med. 1987 Aug 13;317(7):426-32
- Lancet. 1981 Dec 19-26;2(8260-61):1399-402
- Br Med J (Clin Res Ed). 1983 May 7;286(6376):1489-93
- N Engl J Med. 1983 Sep 22;309(12):709-13
- Arch Intern Med. 1985 Apr;145(4):709-12
- N Engl J Med. 1985 Sep 26;313(13):793-9
- Br J Hosp Med. 1987 Apr;37(4):356-7
Source: PubMed
Upcoming Clinical Trials
-
Nicholas ButowskiSiren BiotechnologyNot yet recruitingGlioma | Brain Neoplasm | Recurrent High-Grade GliomasUnited States
-
State University of New York at BuffaloNot yet recruitingPatient EngagementUnited States
-
Poitiers University HospitalNot yet recruiting
-
Assistance Publique - Hôpitaux de ParisNot yet recruitingSickle Cell Disease | Vaso-occlusive Crisis
-
University of California, IrvineRecruitingBrain Cancer | CNS Cancer | Nervous System Cancer | Brain Cancer MetastaticUnited States
-
Qualia Life SciencesRecruiting
-
Guangdong Raynovent Biotech Co., LtdNot yet recruiting
-
The Hong Kong Polytechnic UniversityWu Jieh Yee Charitable FoundationRecruitingAdults | Low Vision Digital Assistance | Visual ImpairmentsHong Kong
-
Shanghai General Hospital, Shanghai Jiao Tong University...Not yet recruitingPancreatic Ductal Adenocarcinoma (PDAC)
-
Sun Yat-sen UniversityNot yet recruitingSmoking Cessation | AI Agent | Early-Stage Cancer
-
Affiliated Hospital of Nantong UniversityNot yet recruiting
-
AIMEDBIOBoehringer IngelheimNot yet recruitingSolid TumoursFrance, Japan, South Korea, United States, Australia